Skip to main content
Michael Blaha, MD, Cardiology, Lutherville, MD

MichaelJosephBlahaMDMPH

Cardiology • Lutherville, MD

Non-Invasive Cardiology, Preventive Cardiology

Professor of Medicine and Epidemiology, Johns Hopkins University School of Medicine; Director of Clinical Research, Ciccarone Center for the Prevention of Cardiovascular Disease

Join to view full profile

Dr. Blaha is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Blaha's full profile

Already have an account?

  • Office

    10755 Falls Road
    Pavilion I STE 360
    Lutherville, MD 21093
    Phone+1 443-997-0270
    Fax+1 410-367-2448

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Cardiovascular Disease, 2009 - 2012
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 2006 - 2009
  • Vanderbilt University School of Medicine
    Vanderbilt University School of MedicineClass of 2006

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2011 - 2026
  • Cardiovascular Disease
    American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
  • Whos Who in Medicine and Healthcare Marquis Whos Who

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Sociodemographic Disparities in Influenza Vaccination Among Adults with Atherosclerotic Cardiovascular Disease in the United States  
    Ron Blankstein, Michael J Blaha, Salim S Virani, Khurram Nasir, JAMA Cardiology
  • Association of Normal Systolic Blood Pressure Level with Cardiovascular Disease in the Absence of Risk Factors  
    Seamus P Whelton, John W Mcevoy, Matthew Budoff, Khurram Nasir, Roger S Blumenthal, Michael J Blaha, JAMA Cardiology
  • Review Article Communication Issues in Nutritional Observational Research  
    Michael J Blaha, Roger S Blumenthal, John W McEvoy, ScienceDirect
  • Join now to see all

Lectures

  • Debate Pro: No Contest! Calcium Scoring Beats Risk Scores and Should be More Broadly Performed 
    2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019

Authored Content

  • Association of Normal Systolic Blood Pressure Level with Cardiovascular Disease in the Absence of Risk FactorsJune 2020
  • Association of Normal Systolic Blood Pressure Level with Cardiovascular Disease in the Absence of Risk FactorsJune 2020
  • Association of Normal Systolic Blood Pressure Level with Cardiovascular Disease in the Absence of Risk FactorsJune 2020
  • Coronary Artery Calcium: Recommendations for Risk Assessment in Cardiovascular Prevention GuidelinesSeptember 2018
  • Impact of C-reactive Protein and Coronary Artery Calcium on Benefit Observed with AtorvastatinMay 2018
  • Impact of C-reactive Protein and Coronary Artery Calcium on Benefit Observed with AtorvastatinMay 2018
  • The Prognostic Value of High Sensitivity C-reactive Protein in a Multi-Ethnic Population After >10 Years of Follow-up: The Multi-Ethnic Study of Atherosclerosis (MESA)May 2018
  • The Prognostic Value of High Sensitivity C-reactive Protein in a Multi-Ethnic Population After >10 Years of Follow-up: The Multi-Ethnic Study of Atherosclerosis (MESA)May 2018
  • Circulating Interleukin-6 Is a Biomarker for Coronary Atherosclerosis in Nonalcoholic Fatty Liver Disease: Results from the Multi-Ethnic Study of AtherosclerosisMarch 2018
  • 10-Year Resource Utilization and Costs for Cardiovascular CareMarch 2018
  • Join now to see all

Press Mentions

  • Study: Obesity Linked with 16 Common Adverse Health Conditions
    Study: Obesity Linked with 16 Common Adverse Health ConditionsMarch 26th, 2025
  • CAC Scans, Statins, and Coaching Can Lower Plaque Volume. Does It Matter?
    CAC Scans, Statins, and Coaching Can Lower Plaque Volume. Does It Matter?March 14th, 2025
  • Less Plaque Progression with CAC-Guided Primary Prevention: CAUGHT-CAD
    Less Plaque Progression with CAC-Guided Primary Prevention: CAUGHT-CADMarch 6th, 2025
  • Join now to see all

Grant Support

  • Coronary Artery Calcium in the PRagmatic EValuation of evENTs And Benefits of Lipid lowering in the Elderly: CAC PREVENTABLE Ancillary StudyDUKE UNIVERSITY2021–2027
  • Aortic Valve Calcium Prevalence, Long-term Risk Factors, and progression to Severe Aortic Stenosis Among Persons >75 Years OldJOHNS HOPKINS UNIVERSITY2025–2026
  • Coronary artery calcium synthetic cohort and lifetime percentile project (CACSC-LPP)JOHNS HOPKINS UNIVERSITY2023–2025
  • Coronary artery calcium synthetic cohort and lifetime percentile project (CACSC-LPP)JOHNS HOPKINS UNIVERSITY2023–2025
  • Coronary artery calcium synthetic cohort and lifetime percentile project (CACSC-LPP)JOHNS HOPKINS UNIVERSITY2023–2025

Professional Memberships

External Links

Dr. Michael Blaha, Dr. Michael Blaha, MD, Dr. M Blaha, Dr. Michael Joseph Blaha